BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3926458)

  • 21. Intracellular processing of prolactin.
    Oetting WS; Walker AM
    Endocrinology; 1985 Oct; 117(4):1565-9. PubMed ID: 4029090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cysteamine depletes prolactin in young and old hyperprolactinemic rats.
    Simpkins JW; Estes KS; Millard WJ; Sagar SM; Martin JB
    Endocrinology; 1983 May; 112(5):1889-91. PubMed ID: 6832077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo and in vitro studies of GABAergic inhibition of prolactin biosynthesis.
    Loeffler JP; Kley N; Pittius CW; Almeida OF; Höllt V
    Neuroendocrinology; 1986; 43(4):504-10. PubMed ID: 3748309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of thyrotropin-releasing hormone on prolactin compartments in normal rat pituitary cells in primary culture.
    Morin A; Rosenbaum E; Tixier-Vidal A
    Endocrinology; 1984 Dec; 115(6):2278-84. PubMed ID: 6437795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of cysteamine, cystamine, and the structurally related compounds taurine, N-acetyl-cysteine, and D-penicillamine on plasma prolactin levels in normal and estrogen-primed hyperprolactinemic rats.
    Scott JS; Lakin CA; Oliver JR
    Endocrinology; 1987 Aug; 121(2):812-8. PubMed ID: 3109888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of prolactin-releasing factor in the rat posterior pituitary.
    Hyde JF; Ben-Jonathan N
    Endocrinology; 1988 Jun; 122(6):2533-9. PubMed ID: 3131118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cysteamine-induced enhancement of growth hormone-releasing factor (GRF) immunoreactivity in arcuate neurons: morphological evidence for putative somatostatin/GRF interactions within hypothalamus.
    Tannenbaum GS; McCarthy GF; Zeitler P; Beaudet A
    Endocrinology; 1990 Nov; 127(5):2551-60. PubMed ID: 1977581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Somatostatin does not inhibit prolactin synthesis in normal male rat pituitary cells but inhibits prolactin synthesis in estradiol-primed pituitary cells.
    Lee SC; Shin SH
    J Endocrinol; 1996 Jan; 148(1):69-76. PubMed ID: 8568473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and release of calcitonin-like immunoreactivity by anterior pituitary cells: evidence for a role in paracrine regulation of prolactin secretion.
    Shah GV; Deftos LJ; Crowley WR
    Endocrinology; 1993 Mar; 132(3):1367-72. PubMed ID: 8440192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular heterogeneity of prolactin in lactating rats and their pups: biological and immunological activities in pituitary gland, serum and milk.
    Kacsóh B; Tóth BE; Avery LM; Yamamuro Y; Grosvenor CE
    Endocr Regul; 1991 Jun; 25(1-2):98-110. PubMed ID: 1958841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation of cleaved prolactin variants that stimulate DNA synthesis in specific cell types in rat pituitary cell aggregates in culture.
    Andries M; Tilemans D; Denef C
    Biochem J; 1992 Jan; 281 ( Pt 2)(Pt 2):393-400. PubMed ID: 1736889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preferential release of newly synthesized prolactin granules is the result of functional heterogeneity among mammotrophs.
    Walker AM; Farquhar MG
    Endocrinology; 1980 Oct; 107(4):1095-104. PubMed ID: 6773746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cysteamine induces a loss of tissue somatostatin-28 when measured as somatostatin-28(15-28)-like immunoreactivity but not when assessed as somatostatin-28(1-14)-like immunoreactivity: evidence for the importance of the disulfide bond for cysteamine action.
    Patel YC; Pierzchala I
    Endocrinology; 1985 May; 116(5):1699-702. PubMed ID: 2859189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presence of immunoreactive vasoactive intestinal polypeptide in anterior pituitary of normal male and long term estrogen-treated female rats: a light microscopic immunohistochemical study.
    Köves K; Gottschall PE; Görcs T; Scammell JG; Arimura A
    Endocrinology; 1990 Mar; 126(3):1756-63. PubMed ID: 1689657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypothalamic and pituitary sites of action of oxytocin to alter prolactin secretion in the rat.
    Lumpkin MD; Samson WK; McCann SM
    Endocrinology; 1983 May; 112(5):1711-7. PubMed ID: 6403333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of galanin gene expression in the rat anterior pituitary gland by the somatostatin analog SMS 201-995.
    Hyde JF; Howard G
    Endocrinology; 1992 Nov; 131(5):2097-102. PubMed ID: 1385097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct suppression by beta-mercaptoethanol of the prolactin immunoreactivity within the cultured rat adenohypophyseal cells.
    Nakamura K; Sato F; Yasuda N
    Horm Metab Res; 1993 Dec; 25(12):603-7. PubMed ID: 8119662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transforming growth factor beta 1-like immunoreactivity in the pituitary gland of the rat: effect of estrogen.
    Burns G; Sarkar DK
    Endocrinology; 1993 Sep; 133(3):1444-9. PubMed ID: 8365375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of cysteamine on suckling-induced prolactin secretion in the rat.
    Millard WJ; O'Sullivan D; Riskind PN
    Life Sci; 1987 Nov; 41(20):2255-60. PubMed ID: 3683075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vesicular release of prolactin from preformed prolactin granules is stimulated by soluble factor(s) from the anterior pituitary of lactating rats.
    Huerta-Ocampo I; Fiordelisio T; Díaz N; Navarro N; Castilla A; Cárabez A; Aguilar MB; Morales T; Hernández-Cruz A; Mena F
    Neuroendocrinology; 2007; 85(1):1-15. PubMed ID: 17341846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.